Results 31 to 40 of about 1,163 (152)

Prevalence of Polypharmacy and Inappropriate Medication in Adults With Intellectual Disabilities in a Hospital Setting in Switzerland

Frontiers in Psychiatry, 2021
Background: Polypharmacy and inappropriate prescription are frequent in vulnerable and multi-morbid populations. Adults with intellectual disability (ID) are at risk of being polymedicated because they often present with multiple comorbidities and ...
Sophie Lonchampt, Sophie Lonchampt, Sophie Lonchampt, Fabienne Gerber, Jean-Michel Aubry, Jules Desmeules, Jules Desmeules, Markus Kosel, Marie Besson   +8 more
doaj   +1 more source

Cannabinoids for behavioral symptoms in severe dementia: Safety and feasibility in a long-term pilot observational study in nineteen patients. [PDF]

, 2022
The management of behavioral symptoms and rigidity in patients with dementia constitutes a significant challenge. Short-term studies suggest an interest in the use of medical cannabis, but long-term data are lacking.
Augsburger, M., Bianchi, F., Broers, B., Curtin, F., Daali, Y., de Saussure, C., Desmeules, J., Pautex, S., Wampfler, J.   +8 more
core   +2 more sources

“Skills for pills”: The dialectical-behavioural therapy skills training reduces polypharmacy in borderline personality disorder [PDF]

, 2022
Objective: Polypharmacy and overprescription of off-label medications are common in patients with borderline personality disorder (BPD). The aim of the present naturalistic study was to explore whether the skills training module of dialectical ...
Almenta, D., Casellas-Pujol, Elisabet, Fernández-Felipe, Isabel, Martin Blanco, Ana, Pascual Mateos, Juan Carlos, Soler, Joaquim, Universitat Autònoma de Barcelona   +6 more
core   +2 more sources

Antidepressant safe use, deprescription and switching guideline [PDF]

Boletín de información farmacoterapéutica de Navarra, 2021
INTRODUCTION Antidepressant use has increased over the past few years. Given the lack of evidence concerning differences in efficacy between the various antidepressants, it is important to understand the safety profile to ensure the safe use thereof.
openaire   +1 more source

Is Deprescription of Ezetimibe Safe in Familial Hypercholesterolemia Patients Taking Evolocumab? [PDF]

CJC Open, 2022
We evaluated whether low-density lipoprotein cholesterol (LDL-C) levels in familial hypercholesterolemia patients on triple lipid-lowering therapy would remain below intensification threshold values after withdrawal of ezetimibe. We included 13 heterozygous familial hypercholesterolemia patients with vascular disease who were treated with statin ...
Shyann Hang, Julieta Lazarte, Robert A. Hegele   +2 more
openaire   +2 more sources

Understanding deprescribing of preventive cardiovascular medication: a Q-methodology study in patients [PDF]

, 2017
Patients with low cardiovascular disease (CVD) risk potentially use preventive cardiovascular medication unnecessarily. Our aim was to identify various viewpoints and beliefs concerning the preventive CVD management of patients with low CVD risk using ...
Boelhouwer, Nelleke J, de Ruijter, Wouter, Luymes, Clare H, Numans, Mattijs E, Poortvliet, Rosalinde K E, Reis, Ria   +5 more
core   +3 more sources

BEHIND THE PROTON PUMP INHIBITOR PRESCRIPTION: AN INTERNATIONAL SURVEY ON PHYSICIAN PRACTICES AND KNOWLEDGE [PDF]

Arquivos de Gastroenterologia
Background: Proton pump inhibitors (PPIs) are widely prescribed worldwide, often resulting in their overuse. Consequently, it is essential to identify the likely causes of this overuse to facilitate their appropriate prescription.
Jean Félix PIÑERÚA-GONSÁLVEZ, Rosanna del Carmen ZAMBRANO-INFANTINO, Julio César ALBORNOZ-SANDOVAL, Pedro Waykin TONG-MORAO, Mariangel Nohemy LEÓN-HERNÁNDEZ, Barbara Daniela MATHEUS-ALONSO, Frank SUÁREZ-LÓPEZ, Yormalis FLORES, Santos Neomar HIGUERA, María Lourdes RUIZ-REBOLLO, Mariseli SULBARAN   +10 more
doaj   +1 more source

Actividades preventivas en el mayor. Actualización PAPPS 2022

Atención Primaria, 2022
Resumen: En este artículo se examina la última evidencia disponible sobre las actividades preventivas en la persona mayor, incluyendo los trastornos de sueño, el ejercicio físico, la deprescripción, los trastornos cognitivos y las demencias, la nutrición,
Miguel Ángel Acosta Benito, Rosa Ana García Pliego, José Miguel Baena Díez, Ana Gorroñogoitia Iturbe, Yolanda Herreros Herreros, M. del Canto De Hoyos Alonso, Purificación Magán Tapia, Iñaki Martin Lesende   +7 more
doaj   +1 more source

How can policies impact the relational process of deprescription? A realist review protocol with an initial theory

Frontiers in Public Health
IntroductionReducing low-value care by deprescribing is a priority. However, current policies often fail due to healthcare provider resistance, lack of incentives, and poor patient engagement.
Jean Macq, María López-Toribio, María López-Toribio, Anne Spinewine   +3 more
doaj   +1 more source

Impact of pharmacist intervention to deprescribe inappropriate aspirin therapy in an outpatient anticoagulation clinic at a community hospital

American Heart Journal Plus, 2022
Study objective: This study describes a pharmacist-led process to identify and discontinue inappropriate aspirin in patients receiving concomitant anticoagulant therapy and to evaluate the effectiveness of the intervention.
Brooke J. Domaleczny, Susan J. Lewis, Jennifer L. Richardson, Heather R. Eid   +3 more
doaj   +1 more source